A monumental midterm wave election over the past half-century has granted Democrats legislative command of both the House and the Senate. Exit polling reveals that widespread voter anxiety concerning healthcare access and affordability was a decisive factor at the ballot box, potentially dictating the political fortunes of both major parties heading into the 2028 presidential race.

Data shows that financial strains—ranging from everyday grocery bills and fuel to medical expenses—remain top of mind for the electorate. Julie Rovner, chief Washington correspondent for KFF Health News, noted in an interview with NPR that medical expenses can escalate rapidly into potentially bankrupting figures, pointing out that recent legislative moves by Republicans have largely inflated healthcare costs for everyday citizens.

According to an analysis of the 2026 Voter Poll by SSRS commissioned by the Kaiser Family Foundation, voters favored Democrats by a 19-point margin on the issue of healthcare management, securing 49% to 30%. Furthermore, individuals who felt their medical expenses deteriorated under President Trump heavily favored Democratic House contenders by an 82% to 16% margin.

As the U.S. Senate prepares to conclude its current legislative term on January 3, 2027, its roster includes four physicians, all of whom are Republicans. While Sens. Bill Cassidy (R-LA) and Roger Marshall (R-KS) failed to secure reelection, Sens. John Barrasso (R-WY) and Rand Paul (R-KY) are set to continue into the 120th Congress.

They will be accompanied by two newly elected Democratic doctor-senators: South Carolina pediatrician Annie Andrews and Michigan public health physician Abdul El-Sayed. Their seating marks a historic milestone, making them the first Democratic medical doctors in the upper chamber since Ernest Gruening—the celebrated architect of Alaska statehood—left office in 1969, though Gruening held an M.D. without maintaining an active clinical practice.

Within the House, the six-member Democratic physicians' caucus is expanding by at least three members: California pediatrician Richard Pan, former Army surgeon Adam Hamawy of New Jersey, and Arizona emergency physician Amish Shah. While two of the 14 Republican doctor-lawmakers lost their bids, neurosurgeon Dr. John Cowan captured a seat in Georgia, with several contests remaining too close to call.

Once the 120th Congress is sworn in on January 3, Democratic leaders intend to pursue rapid legislative remedies centered on medical affordability. Key objectives involve reversing sweeping Medicaid spending reductions embedded in the One Big Beautiful Bill Act and reviving lapsed Affordable Care Act subsidies that were allowed to lapse under Republican watch. Facing potential veto threats from the White House, Democrats aim to attach these measures to essential must-pass funding bills and leverage public hearings to force negotiations or sharpen political contrasts ahead of 2028.

In addition, newly empowered Democratic committees plan to exercise aggressive oversight over federal health agencies and scrutinize the surging influence of healthcare middlemen, such as UnitedHealth Group and CVS Health. Sen. Ron Wyden (D-OR), projected to take the helm of the Senate Finance Committee, distilled his oversight strategy into a single word: subpoenas. Attention will also focus on anti-competitive practices by pharmacy benefit managers, inflated profit margins within Medicare Advantage programs, and the mounting personal and financial tolls of prior authorization protocols.

Beneath these broader legislative aims, party leadership must delicately manage ideological friction between its progressive faction—which favors pushing for Medicare for All—and moderates advocating for incremental reform.

My Prescription For Congress

When an emergency patient arrives in critical condition, emergency physicians first focus on immediate resuscitation by addressing life-threatening issues such as airway obstructions, breathing deficits, or massive hemorrhaging. Only once stability is achieved does the medical team design a long-term roadmap toward recovery.

Congress would be wise to deploy a parallel methodology when treating the systemic ailments of the American medical landscape.

Just two days prior to the convening of the 120th Congress, the Medicaid expenditure reductions codified in the OBBA are scheduled to take effect. If left untouched, these cuts threaten to strip insurance coverage from between 5 million and 10 million low-income Americans. Concurrently, the expiration of ACA subsidies has already forced over two million farmers, freelancers, small business proprietors, and independent workers to abandon their health plans, a figure projected to climb further throughout 2027. Without decisive legislative intervention, an epidemic of hospital and clinic closures could follow, particularly across rural landscapes, ultimately jeopardizing care for both the insured and uninsured. Consequently, the short-term defensive strategy outlined by Democrats is entirely justified, and hopefully, a meaningful bloc of Republicans will cross the aisle to support it.

Rebuilding the structural integrity of our broader healthcare system, however, remains a vastly more arduous challenge. American healthcare commands staggering costs, labyrinthine complexity, restricted accessibility, severe inefficiency, and persistently lags behind peer industrialized nations on crucial metrics like infant mortality, maternal survival rates, and overall life expectancy. Back in 2013, a National Academy of Medicine panel concluded that even affluent Americans possessing higher education degrees and comprehensive insurance coverage frequently experience worse health outcomes and earlier mortality than their international peers.

Given the immense lobbying power of the domestic healthcare complex on Capitol Hill, pursuing a doomed frontal assault is ill-advised. Instead, leadership in the 120th Congress should establish a dedicated bipartisan special committee. This body could evaluate our fragmented medical infrastructure against high-performing, cost-effective models both domestically and internationally to extract best practices. The House Problem Solvers Caucus, alongside newly inducted lawmakers with direct clinical backgrounds, could serve as vital architects for this initiative. Involving the broader public in these deliberations will lay the groundwork for durable reform once the current administration transitions out of power. If bipartisan consensus ultimately fails, the electorate will be presented with a stark and unmistakable choice in 2028.

The late Victor Fuchs, celebrated as the patriarch of American health economics, observed in a 2012 interview that resolving our healthcare expenditure crisis would naturally neutralize nearly all of our broader fiscal burdens. In the years since, inflation-adjusted national health spending has escalated by more than $2.4 trillion.

Trimming per-capita medical expenditures merely to match the spending levels of the world's second-highest cost nation—which guarantees universal coverage—would yield annual savings of $1.7 trillion for American households, private businesses, state governments, and federal coffers alike. This vision is entirely attainable; when Americans unite around a common hurdle, no objective is out of reach.

The opinions and perspectives expressed in this commentary represent solely those of the author.